NEW YORK--(BUSINESS WIRE)--“The race is on for a better mammogram” states the December 19th headline in Fortune Magazine’s (online) story by Sierra Jiminez. The story then begins—and ends—with the breakthrough work of Edward R. Flynn, PhD, of Manhattan Scientifics Inc. (OTCBB: MHTX). Manhattan Scientifics is focused on the technology transfer and commercialization of disruptive technologies in the nano medicine space, including Dr. Flynn's early detection technology.
